This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
CISATRACURIUM BESYLATE — Description, Dosage, Side Effects | PillsCard
OTC
CISATRACURIUM BESYLATE
EQ 2MG BASE/ML, Injectable
INN: CISATRACURIUM BESYLATE
Data updated: 2026-05-09
Available in:
🇨🇿🇩🇪🇬🇧🇸🇰
Form
INJECTABLE
Dosage
EQ 2MG BASE/ML
Route
INJECTION
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
PIRAMAL HEALTHCARE UK LTD
ATC Code
M03AC04
Source
FDA_OB · 212432
USDailyMed:Cisatracurium_besylate
AU:C
M03AC11(WHO)
AU:S4(Prescription only)CA:℞-onlyUK:POM(Prescription only)US:℞-onlyIn general: ℞ (Prescription only)
5-[3-[(1R,2R)-1-[(3,4-Dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-yl]propanoate benzenesulfonate (1:2)
96946-42-8Y96946-41-7
6288662887
DBSALT002671YDB00565
56614Y56615
80YS8O1MBSQX62KLI41N
D00759
CHEBI:3721YCHEBI:140621
ChEMBL1200641NChEMBL1201248
DTXSID10895045
Interactive image
[O-]S(=O)(=O)c1ccccc1.[O-]S(=O)(=O)c1ccccc1.O=C(OCCCCCOC(=O)CC[N@@+]2([C@@H](c1c(cc(OC)c(OC)c1)CC2)Cc3ccc(OC)c(OC)c3)C)CC[N@+]5(C)[C@@H](c4cc(OC)c(OC)cc4CC5)Cc6ccc(OC)c(OC)c6
InChI=1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t42-,43-,54-,55-;;/m1../s1YKey:XXZSQOVSEBAPGS-DONVQRBFSA-LY
Cisatracurium besilate(INN;cisatracurium besylate(USAN); formerly recognized as 51W89;trade nameNimbex) is a bisbenzyltetrahydroisoquinolinium that has effect as a non-depolarizingneuromuscular-blocking drug, used adjunctively inanesthesiato facilitate endotrachealintubationand to provideskeletal musclerelaxation duringsurgeryormechanical ventilation. It shows intermediate duration of action. Cisatracurium is one of the tenisomersof the parent molecule,atracurium.Moreover, cisatracurium represents approximately 15% of the atracurium mixture.
